|
Washington
(H24N).
The first legal alternative to surgical abortion yesterday received
approval from the Food and Drug Administration (FDA) when it approved
the use of the abortion pill RU-486. Advocates of the drug have
tried for 12 years to bring the early-abortion method to this country.
The
drug allows women to terminate pregnancy within seven weeks of their
last menstrual period. It has been sold in Europe and elsewhere
in the world for more than a decade, and an FDA advisory committee
had already recommended approving the drug for this country.
Proponents
say the pill, which has been used by millions of women in 13 countries,
could transform abortion in the United States by making it more
accessible and more private.
Opponents
of legal abortion have urged that the drug not be sold in the United
States. They say it is more dangerous than surgical abortions, causing
severe bleeding in about 2 percent of women and incomplete abortions
in 5 to 8 percent, requiring that the women have surgical abortions
to complete the procedure.
The
drug's maker, the Roussel Ucalf unit of Hoechst A.G., declined to
seek marketing approval for it in the United States, saying it feared
protests from opponents of abortion rights.
In
1994, the company gave the drug's patent to a nonprofit group, the
Population Council, which set out to get market approval.
An
FDA advisory committee recommended four years ago that the drug
be approved, and the agency, under its former commissioner, David
A. Kessler, Ph.D., wrote to the Population Council saying the drug
could be approved if certain conditions were met. But the council
has had difficulty finding a company to make the drug and one to
market it.
To
ensure the pill is used accurately and safely, the FDA mandated
that women be given special brochures called ''MedGuides,'' explaining
who is eligible for a pill-induced abortion and what side effects
to expect, and that they must make three trips to the doctor to
undergo the procedure.
RU-486,
now known by its chemical name mifepristone, can be used only within
49 days of the beginning of the woman's last menstrual period. The
regimen requires the woman to take three mifepristone pills. Two
days later, she returns to the doctor to take a second drug, misoprostol,
which causes uterine contractions to expel the embryo. She returns
for a follow-up visit within two weeks to make sure the abortion
is complete.
|